Genentech Recalls CellCept Capsules Due to Short Fill Issues
Genentech is recalling 1,128 bottles of CellCept (mycophenolate mofetil) 250 mg capsules because some bottles contained fewer than 120 capsules as labeled.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which by definition indicates the product is not likely to cause adverse health consequences. The issue is a packaging/quantity discrepancy (short fill) rather than a contamination or safety defect.
Plain-English summary
Genentech, Inc. is recalling 1,128 bottles of CellCept (mycophenolate mofetil) capsules, 250 mg. The affected product is packaged in 12 x 120-count bottles per carton (NDC 0004-0259-05) and 120-count bottles (NDC 0004-0259-51). The specific lots involved are M1365B01 and M1365, both with an expiration date of 04/15. The product was manufactured in Ireland and distributed nationwide by Genentech USA, Inc.
The recall was initiated due to a "Short Fill" issue, meaning that some bottles contained fewer than 120 capsules than the labeled claim. This is a Class III recall, which indicates that the product is not likely to cause adverse health consequences.
Consumers who have this product should contact Genentech for further instructions or a replacement. The recall is limited to the specific lot numbers and NDC codes listed above.
The recalled product
- Product
- CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDC 0004-0259-05; b) 120-count capsules per bottle, NDC 0004-0259-51; Made in Ireland; Distributed by: Genentech USA, Inc., South San Francisco, CA 94080.
- Manufacturer
- Genentech, Inc.
- Category
- Drug — Immunosuppressant
- Hazard
- Affected units
- 1,128
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: a) M1365B01
- Exp 04/15
- b) M1365
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Genentech, Inc.
See all →- HighCathflo Activase Injection Vials Recalled Due to Deformed Stoppers
FDA (Drugs) · 2024-06-05
- ModerateRanibizumab eye implant recalled for non-functioning delivery system
FDA (Drugs) · 2022-11-09
- ModerateGenentech Xolair Injection Recalled for Failed Stability Specifications
FDA (Drugs) · 2021-07-14
- LowGenentech Recalls Evrysdi Oral Solution Due to Defective Bottle Adapters
FDA (Drugs) · 2021-05-05
- LowGenentech Recalls Klonopin Tablets Due to Missing Schedule IV Labeling
FDA (Drugs) · 2018-02-21
Same hazard · mis labeling
See all →- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02